The Pharmacology Center

Filter Your Results




FDA Grants Priority Review for Supplemental NDA for a Cardiovascular Risk Reduction Indication for Amarin's Vascepa

May 29, 2019 -- Amarin Corporation plc announced that its supplemental new drug application (sNDA) for Vascepav (icosapent ethyl) capsules has been accepted for filing and gra…

SMART-CHOICE Data Show That Stopping Aspirin 3 Months After Stenting Does Not Increase Mortality Risk

March 26, 2019 -- The American College of Cardiology (ACC) announced the presentation of data from the SMART-CHOICE trial that suggest patients who stopped taking aspirin 3 mo…

TREAT Trial Evaluates Safety and Efficacy of Ticagrelor After STEMI

March 26, 2019 -- The TREAT trial demonstrated that ticagrelor's efficacy and safety was equivalent to clopidogrel in data presented at the American College of Cardiology …

Full Results Presented From Phase 1 Trial of PhaseBio's PB2452 Ticagrelor Reversal Agent

March 19, 2019 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that results from the phase 1 clinical trial of PB2452, a novel reversa…

STOPDAPT-2 Data Show Improved Outcomes for Stent Patients on a P2Y12 Inhibitor Who Stop Taking Aspirin After 1 Month

March 18, 2019 -- Data from the STOPDAPT-2 trial show that patients who stopped taking aspirin 1 month after undergoing coronary stenting but continued taking a P2Y12 inhibito…

Two-Year ADAPT-DES Data Examine Relationship of IVUS Guidance on DES Outcomes

November 16, 2018 -- Two-year follow-up data from the large-scale ADAPT-DES study assessing dual-antiplatelet therapy with drug-eluting stents (DESs) implanted with intravenou…

OSLER-1 Evaluates Long-Term Safety and Efficacy of Amgen's Repatha

November 12, 2018 -- Amgen announced the presentation of the final report of the OSLER-1 trial at the American Heart Association (AHA) 2018 scientific sessions held November 1…

REDUCE-IT Trial Evaluates Amarin's Vascepa for Reduction in MACE

November 10, 2018 -- Amarin Corporation plc announced that the results from the REDUCE-IT trial of cardiovascular outcomes of the company's Vascepa (icosapent ethyl) were …



US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.